Rahul Dhanda

Company: Syntis Bio

Job title: Co-Founder, President & Chief Executive Officer

Seminars:

Mechanical Barriers as a Safe, Tolerable, and Sustainable Solution for Obesity Management: SYNT-101 for Weight Loss 1:30 pm

Understanding pharmacologic mechanisms to replicate gastric bypass via oral therapy Developing alternative mechanisms to incretin therapy for safe, sustainable, and effective weight loss Exploring the role of novel mechanisms to preserve lean mass and complement existing solutions while also playing a key role in maintenance therapyRead more

day: Day Two

Panel Discussion: Genetic & Phenotypic Based Approaches to Further Precision Medicine to More Effectively Combat Obesity 4:40 pm

Identifying the key biomarkers and patient characteristics that predict treatment response and adverse events to different obesity medications and interventions. Exploring the ethical and social implications of personalized obesity treatment, including access, equity, and the potential for disparities in care. Developing strategies for integrating personalized medicine approaches into routine clinical practice, including the development of…Read more

day: Day One